This statistic shows the share of drugs in clinical development and regulatory review that have the potential to be first-in-class as of 2016, by therapeutic area. Some 86 percent of Alzheimer's disease drugs in clinical development had the potential to be first-in-class, as of 2016.
Share of products in clinical development and review that had potential to be first-in-class in 2016, by therapeutic area
You have no right to use this feature.
Make sure to contact us if you are interested in scientific citation.
You can upgrade your account to enable this functionality for all statistics.
This feature is not available with your current account.Request access
Learn more about how Statista can support your business.
PhRMA. (July 24, 2018). Share of products in clinical development and review that had potential to be first-in-class in 2016, by therapeutic area [Graph]. In Statista. Retrieved May 05, 2025, from https://www.statista.com/statistics/886380/first-in-class-drug-development-by-therapeutic-area/
PhRMA. "Share of products in clinical development and review that had potential to be first-in-class in 2016, by therapeutic area." Chart. July 24, 2018. Statista. Accessed May 05, 2025. https://www.statista.com/statistics/886380/first-in-class-drug-development-by-therapeutic-area/
PhRMA. (2018). Share of products in clinical development and review that had potential to be first-in-class in 2016, by therapeutic area. Statista. Statista Inc.. Accessed: May 05, 2025. https://www.statista.com/statistics/886380/first-in-class-drug-development-by-therapeutic-area/
PhRMA. "Share of Products in Clinical Development and Review That Had Potential to Be First-in-class in 2016, by Therapeutic Area." Statista, Statista Inc., 24 Jul 2018, https://www.statista.com/statistics/886380/first-in-class-drug-development-by-therapeutic-area/
PhRMA, Share of products in clinical development and review that had potential to be first-in-class in 2016, by therapeutic area Statista, https://www.statista.com/statistics/886380/first-in-class-drug-development-by-therapeutic-area/ (last visited May 05, 2025)
Share of products in clinical development and review that had potential to be first-in-class in 2016, by therapeutic area [Graph], PhRMA, July 24, 2018. [Online]. Available: https://www.statista.com/statistics/886380/first-in-class-drug-development-by-therapeutic-area/
Profit from additional features with an Employee Account
Please create an employee account to be able to mark statistics as favorites.
Then you can access your favorite statistics via the star in the header.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
